Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine ODF vs ziprasidone vs haloperidol for acute agitation in schizophrenia
ChiCTR2200063052Phase 4Not yet recruiting
- Sponsor
- The Third Hospital of Fuyang
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in schizophrenia and agitation (acute) comparing Olanzapine oral dissolution film, Ziprasidone injection and Haloperidol injection (3 arms). Primary endpoints: Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression of overall outcome and 3 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
olanzapineziprasidonehaloperidol
03
Conditions
schizophreniaagitation (acute)
Beyond the preview
Go deeper on ChiCTR2200063052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063052.